Detection of human papillomavirus in matched cervical smears and biopsy specimens by non-isotopic in situ hybridisation.
- 1 April 1992
- journal article
- case report
- Published by BMJ in Journal of Clinical Pathology
- Vol. 45 (4) , 308-313
- https://doi.org/10.1136/jcp.45.4.308
Abstract
To determine the relative diagnostic sensitivity of non-isotopic in situ hybridisation (NISH) for the diagnosis of human papillomavirus (HPV) on matched smears and biopsy specimens; to compare the NISH signal type in the two samples; and to correlate the NISH data with the morphological diagnosis. HPV samples were assayed individually by NISH with digoxigenin labelled probes (HPV6, 11, 16, 18, and 33) on routinely collected paraffin wax embedded cervical biopsy specimens and for high risk HPVs with a cocktail of similarly labelled probes (HPV16, 18, 33) on matched smears. These were taken at the same colposcopic examination from 32 patients investigated for an abnormal cervical Papanicolaou (PAP) stained smear. An HPV signal was present in 18 (56%) biopsy specimens and in 14 (44%) smears. There was higher concordance of sets of data in the presence of cytopathic wart virus changes. The superiority of biopsy over smear in detecting HPV was mainly the result of examining the entire cervical biopsy specimen rather than cells scraped from the cervical surface. The NISH signal type in both biopsy specimen and smear was similar; it has been shown that NISH type 1 signal correlates with episomal viral replication and type 2 and 3 signals with viral integration. These data show that NISH on cervical smears is a worthwhile primary screen for HPV infection. The NISH signal types in cervical smears are similar to those previously described in cervical biopsy specimens.Keywords
This publication has 23 references indexed in Scilit:
- Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation.Journal of Clinical Pathology, 1991
- In situ evidence for HPV 16, 18, 33 integration in cervical squamous cell cancer in Britain and South Africa.Journal of Clinical Pathology, 1991
- In situ human papillomavirus (HPV) genotyping of cervical intraepithelial neoplasia in South African and British patients: evidence for putative HPV integration in vivo.Journal of Clinical Pathology, 1991
- Simultaneous in situ genotyping and phenotyping of human papillomavirus cervical lesions: comparative sensitivity and specificity.Journal of Clinical Pathology, 1991
- Interphase cytogenetics using biotin and digoxigenin labelled probes: III. Increased sensitivity and flexibility for detecting HPV in cervical biopsy specimens and cell lines.Journal of Clinical Pathology, 1991
- HIGH RATE OF HUMAN PAPILLOMAVIRUS TYPE 16 INFECTION IN CYTOLOGICALLY NORMAL CERVICESThe Lancet, 1989
- The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection.BMJ, 1989
- PAPILLOMAVIRUS SCREENING OF CERVICAL LAVAGES BY POLYMERASE CHAIN REACTIONThe Lancet, 1988
- Non-isotopic detection of in situ nucleic acid in cervix: an updated protocol.Journal of Clinical Pathology, 1988
- Prevalence of HPV DNA and viral copy numbers in cervical scrapes from women with normal and abnormal cervicesThe Journal of Pathology, 1987